HealthEquity
303 hedge funds and large institutions have $3.88B invested in HealthEquity in 2019 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 149 increasing their positions, 79 reducing their positions, and 60 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
303
Holders Change
-22
Holders Change %
-6.77%
% of All Funds
6.65%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.09%
New
39
Increased
149
Reduced
79
Closed
60
Calls
$11.8M
Puts
$22.9M
Net Calls
-$11.1M
Net Calls Change
+$14.7M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$168M |
| 2 |
BlackRock
New York
|
+$77.2M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$55.8M |
| 4 |
JSP
Jackson Square Partners
Larkspur,
California
|
+$38.9M |
| 5 |
FAM
Fred Alger Management
New York
|
+$32M |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$25.8M |
| 2 |
D.E. Shaw & Co
New York
|
-$25.1M |
| 3 |
Two Sigma Investments
New York
|
-$21.4M |
| 4 |
Morgan Stanley
New York
|
-$17.8M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$15.7M |
